Yujia Cai

1.7k total citations · 3 hit papers
36 papers, 871 citations indexed

About

Yujia Cai is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Yujia Cai has authored 36 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Yujia Cai's work include CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (11 papers) and RNA Interference and Gene Delivery (6 papers). Yujia Cai is often cited by papers focused on CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (11 papers) and RNA Interference and Gene Delivery (6 papers). Yujia Cai collaborates with scholars based in China, Denmark and United States. Yujia Cai's co-authors include Jacob Giehm Mikkelsen, Rasmus O. Bak, Dawei Wang, Sikai Ling, Jiaxu Hong, Søren R. Paludan, Di Yin, Yao Dai, Xujiao Zhou and Hao Jiang and has published in prestigious journals such as Nucleic Acids Research, Nano Letters and Nature Biotechnology.

In The Last Decade

Yujia Cai

31 papers receiving 858 citations

Hit Papers

Targeting herpes simplex virus with CRISPR–Cas9 cures her... 2021 2026 2022 2024 2021 2024 2025 40 80 120

Peers

Yujia Cai
Thomas W. Chalberg United States
Heide Plesken United States
Jote Bulcha United States
Erin R. Burnight United States
Yue Song China
Martin P. Keough United States
Yujia Cai
Citations per year, relative to Yujia Cai Yujia Cai (= 1×) peers Benjamin Strobel

Countries citing papers authored by Yujia Cai

Since Specialization
Citations

This map shows the geographic impact of Yujia Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Cai more than expected).

Fields of papers citing papers by Yujia Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujia Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Cai. The network helps show where Yujia Cai may publish in the future.

Co-authorship network of co-authors of Yujia Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yujia Cai. A scholar is included among the top collaborators of Yujia Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujia Cai. Yujia Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Dan, Yining Sun, Yu Xia, et al.. (2025). Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming. Advanced Science. 12(34). e03690–e03690. 1 indexed citations
2.
Ling, Sikai, Xue Zhang, Yao Dai, et al.. (2025). Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy. Nature Nanotechnology. 20(4). 543–553. 18 indexed citations breakdown →
3.
Wu, Yu, Weiqing Xu, Yinjun Tang, et al.. (2025). Handheld integrated needle sensor based on arginine-engineered Cu-MOF with boosted enzyme-mimicking activity for sensitive detection of glyphosate. Chinese Chemical Letters. 37(5). 111649–111649. 1 indexed citations
4.
Chen, Guo, Zhilin Long, Yinan Shen, et al.. (2025). BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma. Cell Reports Medicine. 6(8). 102258–102258.
5.
Jiang, Wenxuan, Yu Wu, Rina Su, et al.. (2024). Grain-Boundary-Rich Ceria Metallene Nanozyme with Abundant Metal Site Pairs Boosts Phosphatase-like Activity. Nano Letters. 24(31). 9635–9642. 11 indexed citations
6.
Xu, Weiqing, Yinjun Tang, Yujia Cai, et al.. (2024). Nanozyme-Based Microfluidic Chip System for pH-Regulated Pretreatment and Sensitive Sensing. Analytical Chemistry.
7.
Hu, Jingjing, Xujiao Zhou, Sijia Chen, et al.. (2023). A supramolecular gel with unique rheological properties for treating corneal virus infection. Nano Today. 50. 101841–101841. 15 indexed citations
8.
Yuan, Baoshi, Juanmin Zha, Yujia Cai, et al.. (2023). Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway. Cell Death and Disease. 14(1). 51–51. 10 indexed citations
9.
Cai, Yujia, et al.. (2023). Bacterial molecular syringe for drug delivery. Cell Host & Microbe. 31(6). 917–919.
10.
Li, Yuanqing, Jing Sun, Shiwei Cao, et al.. (2023). Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors. Nature Biotechnology. 42(5). 745–757. 52 indexed citations
11.
Zeng, Xiaofang, et al.. (2022). Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. PLoS ONE. 17(1). e0262833–e0262833. 35 indexed citations
12.
Wang, Fangmin, Wenwen Shen, Yujia Cai, et al.. (2022). Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin/orphanin FQ peptide receptor in rats. Frontiers in Psychiatry. 13. 983595–983595. 5 indexed citations
13.
Yin, Di, Sikai Ling, Dawei Wang, et al.. (2021). Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice. Nature Biotechnology. 39(5). 567–577. 122 indexed citations breakdown →
14.
Ling, Sikai, Shiqi Yang, Xinde Hu, et al.. (2021). Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nature Biomedical Engineering. 5(2). 144–156. 135 indexed citations
15.
Bu, Shizhong, Hong Ma, Lei Gao, et al.. (2020). Preventive and Therapeutic Effects of Astaxanthin on Depressive-Like Behaviors in High-Fat Diet and Streptozotocin-Treated Rats. Frontiers in Pharmacology. 10. 1621–1621. 29 indexed citations
16.
Wang, Dawei, et al.. (2020). An overview of development in gene therapeutics in China. Gene Therapy. 27(7-8). 338–348. 25 indexed citations
17.
Askou, Anne Louise, Emil Aagaard Thomsen, Yujia Cai, et al.. (2017). In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells. Molecular Therapy — Nucleic Acids. 9. 89–99. 60 indexed citations
18.
Cai, Yujia & Jacob Giehm Mikkelsen. (2016). Lentiviral Delivery of Proteins for Genome Engineering. Current Gene Therapy. 16(3). 194–206. 8 indexed citations
19.
Cai, Yujia & Jacob Giehm Mikkelsen. (2014). Driving DNA transposition by lentiviral protein transduction. Mobile Genetic Elements. 4(3). e29591–e29591. 11 indexed citations
20.
Cai, Yujia, et al.. (2013). Efficient Sleeping Beauty DNA Transposition From DNA Minicircles. Molecular Therapy — Nucleic Acids. 2. e74–e74. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026